MR, PET pick best biopsy sites for malignant gliomas

Article

Clinicians can now choose from several MR and PET imaging strategies to identify a brain malignancy's most anaplastic area, according to German researchers.

Clinicians can now choose from several MR and PET imaging strategies to identify a brain malignancy's most anaplastic area, according to German researchers.

Dr. Marc-Andre Weber and colleagues from the German Cancer Research Center and nuclear medicine and radiology departments at the University of Heidelberg examined six approaches performed on 23 patients with gliomas. They found that the methods that single out areas of greatest microcirculation (dynamic contrast-enhanced MRI) and cell proliferation (MR spectroscopy or FLT-PET) are the ones best suited for marking the hot spot and enabling optimal grading of malignant gliomas.

The study was presented at the 2007 International Society for Magnetic Resonance in Medicine meeting.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.